Literature DB >> 3141111

A second variant of properdin deficiency: the detection of properdin at low concentrations in affected males.

A G Sjöholm1, C Söderström, L A Nilsson.   

Abstract

A selective deficiency of properdin (P) was identified in a 58-year-old male and in his 29-year-old nephew, both of whom were clinically healthy. As determined by different immunochemical methods P at low concentrations (about 2 mg/l) was detectable in serum and plasma. Three female relatives, including the mother and daughter of one of the P-deficient males showed moderately low P concentrations. The findings clearly suggested that the deficiency was inherited as an X-linked trait. Three males belonging to another family with P deficiency also showed detectable P concentrations. By contrast, no P (less than 0.1 mg/l) was found in 8 males belonging to three other families. We suggest that there are two variants of X-linked P deficiency: P deficiency type 1, characterized by extremely low P concentrations (less than 0.1 mg/l); and P deficiency type 2 recognizable by P concentrations of about 2 mg/l. The P detected in P deficiency type 2 had subunits of normal molecular weight (52 kilodaltons), but eluted in a lower molecular weight range than did the P of normal serum, either on gel filtration (Ultrogel AcA 22) or on size exclusion chromatography (TSK-4000). The evidence suggested that the P concentration may be one determinant of P oligomer formation. P-deficient serum type 2 did not support fluid phase C3 cleavage in the presence of such alternative pathway activators as inulin and zymosan, nor did it support efficient lysis of guinea pig erythrocytes in agarose gel. By contrast, rabbit erythrocytes were efficiently lyzed, but at a slow rate. P-deficient serum type 1 did not support lysis of rabbit erythrocytes in the assay system used. The reaction was clearly promoted by very low concentrations of purified P. Partially purified P from a male with P deficiency type 2 was shown to be hemolytically active. Further evidence of P function in P deficiency type 2 was obtained by using IgG-presensitized serogroup W-135 meningococci in an alternative pathway-mediated serum bactericidal assay.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3141111     DOI: 10.1159/000463047

Source DB:  PubMed          Journal:  Complement        ISSN: 0253-5076


  8 in total

1.  Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n).

Authors:  P J Späth; A G Sjöholm; G N Fredrikson; G Misiano; R Scherz; U B Schaad; B Uhring-Lambert; G Hauptmann; J Westberg; M Uhlén; C Wadelius; L Truedsson
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  Carrier detection in families with properdin deficiency by microsatellite haplotyping.

Authors:  K Kölble; A J Cant; A C Fay; K Whaley; M Schlesinger; K B Reid
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

3.  Expression of properdin in complete and incomplete deficiency: normal in vitro synthesis by monocytes in two cases with properdin deficiency type II due to distinct mutations.

Authors:  G N Fredrikson; B Gullstrand; J Westberg; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

Review 4.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Cloning and characterization of the cDNA encoding guinea-pig properdin: a comparison of properdin from three species.

Authors:  K K Maves; S T Guenthner; P Densen; D R Moser; J M Weiler
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

Review 6.  Properdin: approaching four decades of research.

Authors:  K K Maves; J M Weiler
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

7.  Immune response to tetravalent meningococcal vaccine: opsonic and bactericidal functions of normal and properdin deficient sera.

Authors:  C Söderström; J H Braconier; H Käyhty; A G Sjöholm; B Thuresson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-03       Impact factor: 3.267

8.  Complement in patients receiving maintenance hemodialysis: functional screening and quantitative analysis.

Authors:  Hiroyuki Inoshita; Isao Ohsawa; Gaku Kusaba; Masaya Ishii; Kisara Onda; Satoshi Horikoshi; Hiroyuki Ohi; Yasuhiko Tomino
Journal:  BMC Nephrol       Date:  2010-12-06       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.